B. Berman

Basal cell carcinoma and actinic keratoses: patients' perceptions of their disease and current treatments

B. Berman, 2001, International journal of dermatology.

Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6.

B. Berman, M. Duncan, M R Duncan, 1991, The Journal of investigative dermatology.

Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts.

B. Berman, M. Duncan, J. Wietzerbin, 1992, The Journal of investigative dermatology.

Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma.

U. Nseyo, B. Berman, M. Duncan, 1991, Scandinavian journal of urology and nephrology.

Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation.

B. Berman, M. Duncan, A. Hasan, 1995, The Journal of investigative dermatology.

Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta.

B. Berman, M. Duncan, B. Berman, 1989, The Journal of investigative dermatology.

Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity.

B. Berman, M. Duncan, B. Berman, 1989, The Journal of investigative dermatology.

Introduction: immunotherapy for dermatological conditions.

D. Rigel, B. Berman, 2003, Acta dermato-venereologica. Supplementum.